News
COVID Concerns: FDA’s New Vaccine Guidelines Raise Questions
Last week, FDA Commissioner Dr. Marty Makary and Dr. Vinay Prasad, director of the FDA’s Center for Biologics Evaluation and Research, outlined the agency’s new approach to COVID shots in an article published in the New England Journal of Medicine.
Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective - and more by some measures - than the original shot, the company said.
1don MSN
Rep. Marjorie Taylor Greene slams FDA green lighting of Moderna's mNEXSPIKE COVID-19 vaccine, describing the move as "Not ...
RFK Jr. will no longer recommend annual COVID-19 vaccines for healthy pregnant women and children, which has sparked much ...
56m
A UCLA professor of clinical obstetrics and gynecology says he still sees more bad outcomes in pregnant patients who have ...
The Centers for Disease Control and Prevention now says that kids with no underlying health conditions "may receive" COVID-19 ...
Cuts in NIH grants and the threat of more are discouraging investment and may drive trials out of the United States.
But in 2024, there was a prolonged summer surge in California that lasted from June through the end of September. After that ...
The World Health Organization has tracked a new COVID-19 variant that has emerged across multiple region. Amid this, the Food ...
A new analysis published late last week in Vaccine concludes that COVID-19 vaccination averted 12,806 COVID-19 deaths among ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback